AbCellera Biologics (ABCL) Short term Debt (2020 - 2025)
AbCellera Biologics (ABCL) posted Short term Debt of $8.8 million for Q1 2025, up 8.46% on a QoQ basis from $8.1 million in Q4 2024, and down 82.95% year-over-year from $51.4 million in Q1 2024.
AbCellera Biologics (ABCL) Short term Debt (2020 - 2025) Analysis & Trends
AbCellera Biologics' Short term Debt history runs 6 years deep, the most recent figure standing at $8.8 million for Q1 2025.
- Quarterly Short term Debt fell 82.95% year-over-year to $8.8 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $8.8 million (down 82.95% YoY) and the FY2024 annual result came in at $8.1 million, down 83.98% from the prior year.
- Short term Debt was $8.8 million for Q1 2025 at AbCellera Biologics, up from $8.1 million in the prior quarter.
- Across five years, Short term Debt topped out at $54.9 million in Q2 2023 and bottomed at $8.1 million in Q4 2024.
- A 5-year average of $30.0 million and a median of $27.5 million in 2022 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2022 — Short term Debt soared 195.99% — and 2024, when it sank 83.98%.
- AbCellera Biologics' Short term Debt stood at $22.9 million in 2021, then soared by 92.77% to $44.2 million in 2022, then grew by 14.17% to $50.5 million in 2023, then sank by 83.98% to $8.1 million in 2024, then increased by 8.46% to $8.8 million in 2025.
- Business Quant data shows ABCL's Short term Debt at $8.8 million in Q1 2025, $8.1 million in Q4 2024, and $20.2 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | AbCellera Biologics | 1.72 Bn | 1.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 8.77 Mn |
| Dec 31, 2024 | 8.09 Mn |
| Sep 30, 2024 | 20.22 Mn |
| Jun 30, 2024 | 20.03 Mn |
| Mar 31, 2024 | 51.43 Mn |
| Dec 31, 2023 | 50.48 Mn |
| Sep 30, 2023 | 53.93 Mn |
| Jun 30, 2023 | 54.87 Mn |
| Mar 31, 2023 | 42.88 Mn |
| Dec 31, 2022 | 44.21 Mn |
| Sep 30, 2022 | 32.53 Mn |
| Jun 30, 2022 | 34.25 Mn |
| Mar 31, 2022 | 27.50 Mn |
| Dec 31, 2021 | 22.93 Mn |
| Sep 30, 2021 | 12.12 Mn |
| Jun 30, 2021 | 11.57 Mn |
| Mar 31, 2021 | 13.76 Mn |
| Dec 31, 2020 | 13.41 Mn |